MedPath

Assessment of Vertebral Fracture Risk for First Time Liver Transplant Candidates

Not Applicable
Completed
Conditions
Metabolic Bone Disease
Secondary Osteoporosis
Transplant-Related Disorder
Registration Number
NCT03811873
Lead Sponsor
Mayo Clinic
Brief Summary

The researchers are trying to compare the effectiveness of Vertebral Fracture Assessment (VFA) in addition to the current standard of care spine x-ray in evaluation pre-liver transplant patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Incident of clinical fractures validated by spine x-ray or other imaging (vertebral fracture assessment -VFA)24 months

Proportion of participants experiencing a clinical fracture validated by x-ray or other imaging (VFA) as compared to standard of care ( Spine X-ray)

Secondary Outcome Measures
NameTimeMethod
Changes in bone mineral density by dual x-ray absorptiometry24 months

Bone mineral density changes seen in end stage liver disease in (grams/cm2) at baseline and 12 months

Changes in bone turnover markers in end stage liver disease24 months

Bone turnover markers (Beta CTX, P1NP) percent changes from baseline to 12 months

Percent changes from baseline to 12 months estimation of bone strength derived from finite element analysis24 months

Bone strength measurements derived from finite element assessment changes from baseline to 12 months and correlation with clinical and radiographic risk of fracture

Trial Locations

Locations (1)

Mayo Clinic in Florida

🇺🇸

Jacksonville, Florida, United States

Mayo Clinic in Florida
🇺🇸Jacksonville, Florida, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.